about
Integrated analysis of pharmacokinetic data across multiple clinical pharmacology studies of prasugrel, a new thienopyridine antiplatelet agent.Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel.Effect of age on the pharmacokinetics and pharmacodynamics of prasugrel during multiple dosing: an open-label, single-sequence, clinical trial.Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males.Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formationThe use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration
P50
Q33561577-2CC8FD78-89F5-4FFE-8F6A-1C9392A1FCCDQ34635528-089F0B86-4A02-44D0-A524-4D58C6439D14Q37807398-C01E8C9E-07BA-46C4-A380-3280DF6F9219Q42632671-30A59AF3-00D9-465A-80CF-1F3535430740Q42646492-07E549B6-E607-4969-9FBC-4CD289F941C7Q43141101-A70E161B-152C-4DFA-A88E-27A7A44D1047Q43248851-75AC9EA8-6BEF-4ED5-8B30-5A4D38E97302Q44406481-0036ECBB-53A7-49CE-8BC6-3563F70E9E3FQ45918033-571F9CE2-A009-4627-994C-3448BF825461Q46119650-D4E98782-3DDB-4AF5-9FC3-CFBA8343E910Q46234082-F6214866-20C8-4D90-80BF-465AF592602BQ46373544-3F858EF8-3622-4AFD-9E4E-F33191E22351Q79438246-BF2BC5F4-601F-482B-9DB6-D027B0490E6EQ80710251-0BDC6F14-9E78-4F7A-BB90-6938F9706FE6
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christopher D Payne
@ast
Christopher D Payne
@en
Christopher D Payne
@es
Christopher D Payne
@nl
Christopher D Payne
@sl
type
label
Christopher D Payne
@ast
Christopher D Payne
@en
Christopher D Payne
@es
Christopher D Payne
@nl
Christopher D Payne
@sl
altLabel
Christopher D Payne
@en
prefLabel
Christopher D Payne
@ast
Christopher D Payne
@en
Christopher D Payne
@es
Christopher D Payne
@nl
Christopher D Payne
@sl
P106
P21
P31
P496
0000-0003-0549-5455